SFGP
BIIB icon

Stonebridge Financial Group (Pennsylvania)’s Biogen BIIB Stock Holding History

Stonebridge Financial Group (Pennsylvania)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11
Closed -$1.5K – 299
2025
Q1 		$1.5K Buy
11
+1
+10% +$143 ﹤0.01% 796
2024
Q4 		$1.53K Buy
+10
New +$1.69K ﹤0.01% 758

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stonebridge Financial Group (Pennsylvania)'s BIIB Position: Q2 2025 in Review

Stonebridge Financial Group (Pennsylvania) sold out of Biogen (BIIB) in Q2 2025, closing a stake of 11 shares — an estimated $1.5K sold.

Stonebridge Financial Group (Pennsylvania) first reported a position in BIIB in Q4 2024 and held it in 2 quarters. The position peaked at $1.53K in Q4 2024. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Stonebridge Financial Group (Pennsylvania) reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • Stonebridge Financial Group (Pennsylvania) sold 11 Biogen shares in Q2 2025, an estimated $1.5K.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Biogen in Q4 2024 and held it in 2 quarters.
  • Stonebridge Financial Group (Pennsylvania)'s Biogen position peaked at $1.53K in Q4 2024.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2025, filed 24 Jul 2025.